Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2014
Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversalLi Li, Rui Han, Hualiang Xiao, et al.Biomimetics (Basel, Switzerland)|June 27, 2023
Biomimetic Scaffolds for Tendon Tissue RegenerationLvxing Huang, Le Chen, Hengyi Chen, et al.Frontiers in Cellular Neuroscience|October 18, 2021
Molecular Expression Profile of Changes in Rat Acute Spinal Cord InjuryJun-Juan Wang, Guo Ye, Hao Ren, et al.Biomaterials|September 9, 2023
Ultra-efficient radio-immunotherapy for reprogramming the hypoxic and immunosuppressive tumor microenvironment with durable innate immune memoryJichun Yang, Chong Zhang, Xiaohui Chen, et al.Biomaterials|November 26, 2025
Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapyQianqian Wu, Xiaohui Chen, Sitong Wang, et al.Bioactive Materials|December 16, 2025
Turmeric extracellular vesicles-derived "all-in-one" nanoagent enables full-cycle synergistic immunomodulation of lung cancerJichun Yang, Qianqian Wu, Yunqian Fu, et al.ACS Nano|August 15, 2025
A Spatiotemporally Controllable DNA Hydrogel Mesh for Focused Antimetastasis Therapy of CancerJichun Yang, Yuhan Wang, Kang Wang, et al.ACS Nano|April 19, 2021
Flipped Quick-Response Code Enables Reliable Blood GroupingHong Zhang, Ruining Liu, Qingmei Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2019
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II TrialLi Li, Liyan Jiang, Yubo Wang, et al.Pageof 4